The METTL3 inhibitor STM2457 suppresses gastric cancer progression by modulating m6A RNA modification.

Saved in:
Bibliographic Details
Title: The METTL3 inhibitor STM2457 suppresses gastric cancer progression by modulating m6A RNA modification.
Authors: Sun, Hang1 (AUTHOR), Xu, Haozhi1,2 (AUTHOR), Li, Junying3 (AUTHOR), Xie, Xiaoman1 (AUTHOR), Zhang, Junmei1 (AUTHOR), Dong, Hongjie1 (AUTHOR), Xie, Huanhuan1 (AUTHOR), Wang, Qi1 (AUTHOR), Zhao, Guihua1 (AUTHOR), Yin, Kun1 (AUTHOR), Yang, Jingyu2 (AUTHOR), Zhou, Jianwei4 (AUTHOR) immunolife@126.com, Wu, Ruili2 (AUTHOR) wrl3602@hotmail.com, Xu, Chao1 (AUTHOR) xu0927@hotmail.com
Source: PLoS ONE. 3/24/2026, Vol. 21 Issue 3, p1-14. 14p.
Database: Academic Search Ultimate
Full text is not displayed to guests.
Description
ISSN:19326203
DOI:10.1371/journal.pone.0345744